These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23555571)

  • 1. Factors associated with esophageal candidiasis and its endoscopic severity in the era of antiretroviral therapy.
    Nishimura S; Nagata N; Shimbo T; Asayama N; Akiyama J; Ohmagari N; Yazaki H; Oka S; Uemura N
    PLoS One; 2013; 8(3):e58217. PubMed ID: 23555571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between clinical factors and severity of esophageal candidiasis according to Kodsi's classification.
    Asayama N; Nagata N; Shimbo T; Nishimura S; Igari T; Akiyama J; Ohmagari N; Hamada Y; Nishijima T; Yazaki H; Teruya K; Oka S; Uemura N
    Dis Esophagus; 2014 Apr; 27(3):214-9. PubMed ID: 23826847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.
    Nagata N; Shimbo T; Yazaki H; Asayama N; Akiyama J; Teruya K; Igari T; Ohmagari N; Oka S; Uemura N
    PLoS One; 2012; 7(11):e46967. PubMed ID: 23226197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients.
    Takahashi Y; Nagata N; Shimbo T; Nishijima T; Watanabe K; Aoki T; Sekine K; Okubo H; Watanabe K; Sakurai T; Yokoi C; Kobayakawa M; Yazaki H; Teruya K; Gatanaga H; Kikuchi Y; Mine S; Igari T; Takahashi Y; Mimori A; Oka S; Akiyama J; Uemura N
    PLoS One; 2015; 10(7):e0133589. PubMed ID: 26208220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy.
    Chiou CC; Groll AH; Mavrogiorgos N; Wood LV; Walsh TJ
    Pediatr Infect Dis J; 2002 May; 21(5):388-92. PubMed ID: 12150174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy.
    Mönkemüller KE; Lazenby AJ; Lee DH; Loudon R; Wilcox CM
    Dig Dis Sci; 2005 Feb; 50(2):230-4. PubMed ID: 15745077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
    J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with 10 years of continuous viral load suppression on HAART.
    Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF
    BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamic changes of oral candida infection and immune status of 46 HIV/AIDS patients during the first year of highly active antiretroviral therapy].
    DU X; Xiong H; Yang Y; Chen FC
    Shanghai Kou Qiang Yi Xue; 2021 Jun; 30(3):263-267. PubMed ID: 34476442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.
    Jones CY; Tang AM; Forrester JE; Huang J; Hendricks KM; Knox TA; Spiegelman D; Semba RD; Woods MN
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):475-82. PubMed ID: 17019373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
    Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
    Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esophageal pathology in patients with the AIDS virus. Etiology and diagnosis].
    Varsky CG; Yahni VD; Freire MC; Patrizio E; Balbo V; Benetucci J; Boffi A; Mattoni RA; Luis ; Alicia M
    Acta Gastroenterol Latinoam; 1991; 21(2):67-83. PubMed ID: 1820692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life.
    Gill CJ; Griffith JL; Jacobson D; Skinner S; Gorbach SL; Wilson IB
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):485-92. PubMed ID: 12154339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China].
    Wen Y; Li C; Pei J; Bai J; Yang X; Duan K
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of HIV associated oral lesions among adults in the era of HAART.
    Mthethwa SR; Wanjau J; Chabikuli N
    SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDS.
    Marconi VC; Grandits G; Okulicz JF; Wortmann G; Ganesan A; Crum-Cianflone N; Polis M; Landrum M; Dolan MJ; Ahuja SK; Agan B; Kulkarni H;
    PLoS One; 2011; 6(5):e17956. PubMed ID: 21625477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall trends in CD4 counts and plasma viremia in an urban clinic since the introduction of highly active antiretroviral therapies.
    Martín JC; Soriano V; Jiménez-Nácher I; Martínez P; González-Lahoz J
    Clin Microbiol Infect; 2001 Dec; 7(12):678-81. PubMed ID: 11843909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.